EJNMMI Radiopharmacy and Chemistry

SpringerOpen

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

EJNMMI Radiopharmacy and Chemistry is an open-access journal published by SpringerOpen in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 1,990 EUR. Declared review time at DOAJ: 5 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
SpringerOpen
ISSN
2365-421X
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
1,990 EUR
Articles in DOAJ
463
Declared review time
5 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2018-04-30
  • PUBMED · 2019-01-10
Indexing
DOAJ · PUBMED
APC
1,990 EUR
Declared review time (DOAJ)
5 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

463

Most recent article

last month

Average review time (journal-declared via DOAJ)

5weeks

Works in OpenAlex

457

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

41

i10-index

154

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-17
Added to DOAJ
2018-04-30
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSS
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
90%
ORCID iDs in current deposits
92%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101714628
Classification4

Subjects (DOAJ)

Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicineMedicine: Therapeutics. Pharmacology

LCC codes

R895-920RM1-950

Subject areas

  • Radiopharmaceutical Chemistry and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Medical Imaging Techniques and Applications
  • Chemical Reactions and Isotopes
  • Medical Imaging Techniques and Applications
  • Medical Imaging Techniques and Applications
  • Peptidase Inhibition and Analysis
Show all subjects (75)
  • Peptidase Inhibition and Analysis
  • Neuroendocrine Tumor Research Advances
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research
  • Radioactive Decay and Measurement Techniques
  • Radioactive Decay and Measurement Techniques
  • Peptidase Inhibition and Analysis
  • Chemical Reactions and Isotopes
  • Neuroendocrine Tumor Research Advances
  • Neuroendocrine Tumor Research Advances
  • Chemical Reactions and Isotopes
  • Medical Imaging and Pathology Studies
  • Medical Imaging and Pathology Studies
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Radioactive Decay and Measurement Techniques
  • Cancer, Hypoxia, and Metabolism
  • Boron Compounds in Chemistry
  • Click Chemistry and Applications
  • Click Chemistry and Applications
  • Boron Compounds in Chemistry
  • Cancer, Hypoxia, and Metabolism
  • Orthopedic Infections and Treatments
  • Neuropeptides and Animal Physiology
  • Analytical Methods in Pharmaceuticals
  • Lung Cancer Treatments and Mutations
  • Orthopedic Infections and Treatments
  • Neuropeptides and Animal Physiology
  • Lung Cancer Treatments and Mutations
  • Lanthanide and Transition Metal Complexes
  • Radiation Therapy and Dosimetry
  • Radiation Therapy and Dosimetry
  • Glioma Diagnosis and Treatment
  • Lanthanide and Transition Metal Complexes
  • Monoclonal and Polyclonal Antibodies Research
  • Radiology practices and education
  • Glioma Diagnosis and Treatment
  • Fluorine in Organic Chemistry
  • Amino Acid Enzymes and Metabolism
  • Nuclear physics research studies
  • Amino Acid Enzymes and Metabolism
  • Lung Cancer Research Studies
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Lung Cancer Research Studies
  • Chemical Synthesis and Analysis
  • Nanoplatforms for cancer theranostics
  • Nuclear Physics and Applications
  • Fluorine in Organic Chemistry
  • Fluorine in Organic Chemistry
  • Chemical Synthesis and Analysis
  • Alzheimer's disease research and treatments
  • Orthopaedic implants and arthroplasty
  • Orthopaedic implants and arthroplasty
  • Effects of Radiation Exposure
  • Drug Transport and Resistance Mechanisms
  • Drug Transport and Resistance Mechanisms
  • Healthcare Regulation
  • Radiation Therapy and Dosimetry
  • Nanoparticle-Based Drug Delivery
  • Radioactive element chemistry and processing
  • Prostate Cancer Diagnosis and Treatment
  • Cancer, Hypoxia, and Metabolism
  • Cancer Immunotherapy and Biomarkers
  • Chemical Synthesis and Analysis
  • Radioactivity and Radon Measurements
  • Neuropeptides and Animal Physiology

Keywords (DOAJ)

  • nuclear medicine
  • radiochemistry
  • radiology
  • molecular imaging
  • radiopharmaceuticals

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: